Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Dow: ‘Active Comfort’ Nonwoven Resins

ASPUN MB Meltblown fiber PE resins address consumer demand for softer, cloth-like materials for a variety of medical applications.

ASPUN MB Meltblown fiber PE resins address consumer demand for softer, cloth-like materials for a variety of medical applications.
ASPUN MB Meltblown fiber PE resins address consumer demand for softer, cloth-like materials for a variety of medical applications.

Dow Packaging and Specialty Plastics (P&SP), a business unit of The Dow Chemical Co., offers resins that provide converters and brand owners options for improved comfort and softness, with performance characteristics in nonwoven applications.

ASPUN™ Meltblown fiber resins address the difficult challenges of increasing softness and comfort in fabrics such as bico-SMS nonwovens. This patent-pending family of polyethylene (PE) resins is suitable for nonwovens in diapers, wipes, medical drapes and garments, sterilization packs, filtration, and other hygiene and medical applications where increased softness provides added value.

Is your palletizing solution leaving money on the floor?
Discover which palletizing technology—robotic, conventional, or hybrid—will maximize your packaging line efficiency while minimizing long-term costs in this comprehensive analysis.
Read More
Is your palletizing solution leaving money on the floor?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report